A - Human Necessities – 61 – M
Patent
A - Human Necessities
61
M
A61M 5/158 (2006.01) A61K 9/70 (2006.01) A61K 31/395 (2006.01) A61M 37/00 (2006.01) A61N 1/30 (2006.01) A61K 9/00 (2006.01)
Patent
CA 2452393
A method for systemic administration of a hydrophobic dopamine agonist to a mammal is disclosed. The method involves delivering t he hydrophobic dopamine agonist to the dermis of the mammal whereby improved systemic absorption is obtained compared to absorption produced upon delivering the substance subcutaneously by bolus administration.
L'invention porte sur un procédé d'administration systémique d'un agoniste hydrophobe de la dopamine à un mammifère. Le procédé consiste à injecter l'agoniste hydrophobe de la dopamine dans le derme du mammifère, ce qui permet d'obtenir une meilleure absorption systémique comparée à l'absorption produite lors de l'injection par voie sous-cutanée de la substance par administration du bol alimentaire.
Osler Hoskin & Harcourt Llp
Pharmacia Corporation
LandOfFree
Hydrophobic dopamine agonists administered to the dermis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydrophobic dopamine agonists administered to the dermis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydrophobic dopamine agonists administered to the dermis will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1763537